Access
Email Verification
Agenda 2022
DAY 1: TBC
0830 - 0930 REGISTRATION AND MORNING REFRESHMENTS
0930 - 0940 OPENING ADDRESS
0940 - 1010 RESERVED PRESENTATION
1010 - 1030 SPEED NETWORKING SESSION
- SPEED NETWORKING SESSION
- Exchange business cards and get connected in short one-to-one meetings
- Start the conversation to arrange a more formal meeting later on in the conference
- Share your professional background and discuss your biggest business issues - Don't forget your business cards!
Conference Host
1030 - 1100 MORNING COFFEE BREAK IN EXHIBIT AREA
1100 - 1130 INCREASED EFFICACY AND PATIENT CONVENIENCE WITH ORAL DRUG DELIVERY
- Making substitution of injection to pain-free application
- Predicting the increase of bioavailability by circumventing the 1st pass metabolism
Timo Taghizadeh
tesa Labtec
tesa Labtec
1130 - 1200 NANOCIN: A NOVEL AND CLINICAL STAGE DRUG DELIVERY PLATFORM
- Understand the scope of areas of applications for APIs and routes of administration
- Looking at the example formulations and applications for biologics and small molecules
Liam Good
Tecrea
Tecrea
1200 - 1330 NETWORKING LUNCH & VISIT DRUG DELIVERY EXHIBITION
1330 - 1400 DESIGN OF INJECTABLE HYDROGELS FOR TARGETED AND CONTROLLED DRUG DELIVERY
- Understand the formulation of peptide and polymer based hydrogels for targeted delivery via injection and endoscopy
- Advances in controlling the kinetics of drug release through material design
Aline Miller
University of Manchester
University of Manchester
1400 - 1430 CLOUD-CONNECTED NEEDLE-FREE INJECTION TECHNOLOGY
- Needle-free injector device vs. traditional needle and syringe injections
- Introducing next-gen needle-free, computer controlled drug delivery platform
- Developing cloud connected needle-free injector device to empower patients
Patrick Anquetil
Portal Instruments
Portal Instruments
1430 - 1500 AFTERNOON COFFEE BREAK IN EXHIBIT AREA
1500 - 1530 RESERVED PRESENTATION
1530 - 1600 SOFT MIST INHALERS (SMI) FOR INHALED PRODUCT DEVELOPMENT
- Introducing SMI for patient friendly, cost-effective alternative to existing delivery devices
- Looking at the case studies on soft mist inhaler performance
Bernhard Müllinger
Resyca
Resyca
1600 - 1700 NETWORKING DRINKS RECEPTION
DAY 2: TBC
0900 - 0930 MORNING REFRESHMENTS
0930 - 0940 OPENING ADDRESS
0940 - 1010 A DISRUPTIVE TECHNOLOGY FOR MANUFACTURING OF LIPID NANOPARTICLES
- Looking at the limitations and challenges of currently available manufacturing capacities for the fast-growing personalized medicine market
- Understand the LEONs solution to overcome market challenges and hurdles
Andrea Cusack
leon-nanodrugs GmbH
leon-nanodrugs GmbH
1010 - 1040 IN-SILICO SCREENING TECHNIQUES FOR AMORPHOUS DRUG FORMULATIONS
- Introducing in-silico formulation screenings for finding suitable excipients for newly developed drugs
- Advances in in-silico formulation screenings to stabilize the amorphous form of poorly bioavailable drugs
- Predict the impact of harsh storage conditions at early stages of formulation development
Christian Lübbert
Amofor
Amofor
1040 - 1100 MORNING COFFEE BREAK IN EXHIBIT AREA
1100 - 1130 INTELLIGENT FORMULATION DESIGN AND EVALUATION FOR SWIFT PRODUCT DEVELOPMENT
- Understanding the challenges of the GI tract and limitations of in vitro simulation of product performance
- Integrating biopharmaceutics with intelligent formulation design to maximise chances of clinical success
- Accelerating product development with adaptive clinical trials for rapid clinical proof of concept
Fiona MacDougall
BDD Pharma
BDD Pharma
1130 - 1200 DRUG DELIVERY TECHNOLOGY FOR BIOLOGICS THROUGH NEBULISATION
- Advanced formulation of biologics for nasal delivery
- Development in macro-molecules being nebulised
Elijah Nazarzadeh
Nebu~Flow
Nebu~Flow
1200 - 1230 RESERVED PRESENTATION
1230 - 1400 NETWORKING LUNCH & RAFFLE DRAW
Key topics for 2022:
- Formulation design for poorly soluble compounds
Understand the most recent advancements in technologies to improve the dissolution and bioavailability of poorly soluble drugs. - New drug delivery technologies for better deliverability
The future of drug deliveries across the skin barrier to systemic circulation via Iontophoresis, electroporation, sonophoresis, magnetophoresis, dermal patches, nanocarriers, needled and needle-less shots. - Latest developments in controlled released technologies
Evaluate controlled release methods which enhance the safety, efficacy, reliability, and convenience of drug therapy by controlling the rate and duration of drug release to control drug actions. - Optimising drug formulations for continuous manufacturing
Learn about new methods in continuous pharmaceutical manufacturing for the pharmaceutical industry which offers the potential for cost-reduction, enhanced efficiency, and economic viability. - Overcoming the blood-brain barrier and re-engineering biologics
Looking at the structural elements and anatomical features of the blood–brain barrier, various in vivo, in situ blood–brain barrier models, and adopting molecular Trojan horse technologies. - Developing new drug modalities and biotherapeutics
Achieve a deeper understanding of biotherapeutics and novel drug modalities beyond traditional small molecules, including RNA-based approaches, targeted protein degradation, covalent inhibitors, next generation of peptides, and antibodies.
Sponsorship Opportunities
Join us as a sponsor for this IQ International conference! Reach your target audience, limit competitor influence at the conference and become a keynote speaker, while sharing your company's solutions for this industry.
- Get registration discounts
- Enhance your brand awareness
- Additional marketing opportunities